CHEBI:133007 - Descovy

ChEBI IDCHEBI:133007
ChEBI NameDescovy
Stars
DefinitionA mixture composed of emtricitabine and tenofovir alafenamide fumarate (trade name Descovy) that is used in combination with other antiretroviral agents, for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older.
Last Modified15 August 2016
SubmitterSteve
Roles Classification
Biological Roles:
antiviral drug  A substance used in the prophylaxis or therapy of virus diseases.
HIV-1 reverse transcriptase inhibitor  An entity which inhibits the activity of HIV-1 reverse transcriptase.
Application:
antiviral drug  A substance used in the prophylaxis or therapy of virus diseases.
ChEBI Ontology
Outgoing Relation(s)
Descovy (CHEBI:133007) has part emtricitabine (CHEBI:31536)
Descovy (CHEBI:133007) has part tenofovir alafenamide fumarate (CHEBI:90923)
Descovy (CHEBI:133007) has role antiviral drug (CHEBI:36044)
Descovy (CHEBI:133007) has role HIV-1 reverse transcriptase inhibitor (CHEBI:53756)
Descovy (CHEBI:133007) is a mixture (CHEBI:60004)
Synonyms  Source
Tenofovir Alafenamide and EmtricitabineChemIDplus
Emtricitabine and Tenofovir AlafenamideChemIDplus
Tenofovir Alafenamide/EmtricitabineChemIDplus
Emtricitabine mixture with Tenofovir AlafenamideChemIDplus
Emtricitabine/Tenofovir AlafenamideChemIDplus
Registry NumbersSources
CAS:731772-56-8ChemIDplus
Citations